Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #689673 on NorthWest Biotherapeutics Inc (NWBO)
hankmanhub
05/08/24 1:33 PM
#689678 RE: exwannabe #689673
CVM and NWBO are pees in a pod.
CherryTree1
05/08/24 1:43 PM
#689682 RE: exwannabe #689673
Both with single P3 failed for futility.
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma A Phase 3 Prospective Externally Controlled Cohort Trial Conclusions This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statistically significant extension of overall survival in both nGBM and rGBM. Treatment with DCVax-L also had an excellent safety profile and noteworthy tails of long-term survival curves.